SDM Sulfadimethoxine 12.5% Strategic Uses, Dosage, Side Effects and more
SDM Sulfadimethoxine 12.5% Strategic is a sulfonamide antibiotic. SDM Sulfadimethoxine 12.5% Strategic is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. SDM Sulfadimethoxine 12.5% Strategic inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. SDM Sulfadimethoxine 12.5% Strategic is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies.
SDM Sulfadimethoxine 12.5% Strategic has been shown to be effective against streptococci, klebsiella, proteus, shigella, staphylococci, escherichia, and salmonella.
Trade Name | SDM Sulfadimethoxine 12.5% Strategic |
Generic | Sulfadimethoxine |
Sulfadimethoxine Other Names | Sulfadimethoxine, Sulfadimethoxinum, Sulfadimethoxydiazine, Sulfadimetoxina, Sulphadimethoxine |
Type | |
Formula | C12H14N4O4S |
Weight | Average: 310.329 Monoisotopic: 310.073575646 |
Groups | Approved, Vet approved |
Therapeutic Class | |
Manufacturer | |
Available Country | USA |
Last Updated: | January 7, 2025 at 1:49 am |
Uses
For use in the treatment of infections.